IMMUNORESPONSIVE CELLS EXPRESSING DOMINANT NEGATIVE FAS AND USES THEREOF
Patent Cooperation Treaty
PCT/US2019/053825
Filed on 2019-09-30
PCT/US2019/053825
Filed on 2019-09-30
Methods for Decreasing Influenza-Induced Lethality using Gastrin-Releasing Peptide (GRP) Inhibitors or Gastrin-Releasing Peptide Receptor (GRPR) Antagonists
US Application 17/274,564
Filed on 2021-03-09
Filed on 2021-03-09
Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
India
202118011347
Filed on 2021-03-17
202118011347
Filed on 2021-03-17
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST LMP2
Patent Cooperation Treaty
PCT/US2021/026883
Filed on 2021-04-12
PCT/US2021/026883
Filed on 2021-04-12
HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
European Patent
19805442.1
Filed on 2021-05-20
19805442.1
Filed on 2021-05-20
HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Canada
3116749
Filed on 2021-04-15
3116749
Filed on 2021-04-15
HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
Australia
2019364436
Filed on 2021-04-21
2019364436
Filed on 2021-04-21
CELL LINKERS FOR HETEROTYPIC CELL SPHEROIDS
US Application 17/260,365
Filed on 2021-01-14
Filed on 2021-01-14
CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY
Hong Kong
62021027359.0
Filed on 2021-03-16
62021027359.0
Filed on 2021-03-16
T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage
Japan
2021-043845
Filed on 2021-03-17
2021-043845
Filed on 2021-03-17